These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5551689)

  • 1. Transitory procaine-induced Parkinsonism.
    Gjerris F
    J Neurol Neurosurg Psychiatry; 1971 Feb; 34(1):20-2. PubMed ID: 5551689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Attempt at treating parkinsonism with L-dopa and Artane].
    Stelmasiak Z; Lackowska H; Maksymowicz B
    Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
    Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
    Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
    Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of parkinsonism with artane and slow release artane.
    Pakkenberg H
    Dan Med Bull; 1966 Nov; 13(8):204. PubMed ID: 5978771
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of L-DOPA on pharmacological parkinsonism.
    Bruno A; Bruno SC
    Acta Psychiatr Scand; 1966; 42(3):264-71. PubMed ID: 5335155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined treatment of parkinsonism with L-dopa and Parkopan].
    Lukasiewicz K
    Wiad Lek; 1977 May; 30(10):775-7. PubMed ID: 867994
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG; Kistenev BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies.
    Dreyfuss J; Beer B; Devine DD; Roberts BF; Schreiber EC
    Neuropharmacology; 1972 Mar; 11(2):223-30. PubMed ID: 4623662
    [No Abstract]   [Full Text] [Related]  

  • 10. L-DOPA therapy in drug-induced parkinsonism evaluated by the method measuring the facial expression.
    Kimura N; Tsukue I
    Hiroshima J Med Sci; 1971 Mar; 20(1):55-63. PubMed ID: 5121129
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacology of parkinsonism (a review).
    Klawans HL
    Dis Nerv Syst; 1968 Dec; 29(12):805-16. PubMed ID: 4388368
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of biperiden hydrochloride (Akineton) and benzhexol (Artane) in the treatment of drug-induced Parkinsonism.
    Magnus RV
    J Int Med Res; 1980; 8(5):343-6. PubMed ID: 7418951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
    Evtushenko SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa in the treatment of Parkinsonism.
    Cotzias GC
    JAMA; 1971 Dec; 218(13):1903-8. PubMed ID: 5171066
    [No Abstract]   [Full Text] [Related]  

  • 15. L-dopa in Parkinsonism associated with cerebellar dysfunction (probable olivopontocerebellar degeneration).
    Klawans HL; Zeitlin E
    J Neurol Neurosurg Psychiatry; 1971 Feb; 34(1):14-9. PubMed ID: 5551687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon monoxide-induced Parkinsonism.
    Ringel SP; Klawans HL
    J Neurol Sci; 1972 Jul; 16(3):245-51. PubMed ID: 5038884
    [No Abstract]   [Full Text] [Related]  

  • 17. Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF; Ni L
    Exp Neurol; 1998 Aug; 152(2):238-42. PubMed ID: 9710523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism].
    Fujimori N; Kito S; Yamamoto M; Itoga E; Kosaka K
    Nihon Rinsho; 1974 Mar; 32(3):579-86. PubMed ID: 4859014
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.
    Freeman H; Mehta IS
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):470-7. PubMed ID: 4629309
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of parkinsonism with benzhexole (Artane and Artane-sequel)].
    Vestberg F
    Ugeskr Laeger; 1967 Nov; 129(45):1511-2. PubMed ID: 5594302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.